Return to List

Hunan Bio-essential API glutathione successfully transitions to "A"

2025-07-16

Recently, the active pharmaceutical ingredient (API) glutathione (Y20230001015) of Hunan BIO essential co ltd, a wholly-owned subsidiary of Flag, successfully changed its status to "A" at the Center for Drug Evaluation of the National Medical Products Administration. This indicates that our company's API has passed the review and approval process. 

Glutathione is a tripeptide composed of glutamic acid, cysteine and glycine, containing a sulfhydryl group. It has the functions of integrating detoxification and antioxidation, and can help maintain normal immune system function. Glutathione drugs are widely used in clinical practice to treat various liver diseases such as alcoholic hepatitis and drug-induced hepatitis, and are also used in the auxiliary treatment of hemolytic diseases, as well as keratitis, cataracts and retinal diseases. 

The achievement of the "A" transformation of glutathione is of great significance to the company's future development. Flag and Hunan BIO will continue to focus on the innovation and research and development of products, further improve the production process and quality management system, enhance the level of large-scale production, and provide more high-quality products and services to global customers.

TAG: